Cargando…
Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
Rituximab (RTX) is an effective treatment for pemphigus; however, the drug labeling recommends not to use RTX within 1 year before conception. OBJECTIVES: To report pregnancy outcomes of patients with pemphigus who were treated with RTX before or during pregnancy. METHODS: We identified 19 pregnanci...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276145/ https://www.ncbi.nlm.nih.gov/pubmed/35837335 http://dx.doi.org/10.1097/JW9.0000000000000038 |